The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ARGX FINANCIAL STATEMENTS

argenx NV ADR — balance sheet, income statement and cash flow trends

ARGXargenx NV ADR

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
02.5 B5 B7.5 B20202022202420252026

Profit Funnel

Q2 2026 · TTM
Revenue8.4 B $Gross Profit7.6 B $ · 90%Operating Income2.4 B $ · 29%Pre-tax Income2.8 B $ · 33%Net Income to Owners2.6 B $ · 31%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue8.4 B $+130.9%
Gross Profit7.6 B $+177.0%
Operating Income2.4 B $+412.4%
EBITDA1.9 B $+165.0%
Net Income to Owners2.6 B $+89.2%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
05 B10 B20202022202420252026

Capital Structure

Q2 2026
Total Assets10 B
  • Equity8.4 B $84%
  • Current Liabilities1.6 B $16%
  • Long-term Liabilities40 M $0%

Key Figures

YoY change
Total Assets10 B $+39.8%
Total Liabilities1.6 B $+49.6%
Total Equity8.4 B $+38.1%
Cash & ST Investments5.2 B $+32.0%
Total Debt47 M $+8.9%
Net Debt-3.5 B $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-500 M0500 M1 B20202022202420252026

Cash Flow Bridge

Q2 2026 · TTM
0500 M1 B1.5 B1.2 B $Operating70.8 M $Investing262.4 M $Financing1.5 B $Net Change

Key Figures

YoY change
Operating Cash Flow1.2 B $+141.7%
Capital Expenditures3.9 M $-37.4%
Free Cash Flow1.2 B $+144.0%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ARGX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.